ASCO Heard in the Halls: Dr. Spetzler on Agentic AI & Whole Genome Sequencing in Precision Oncology
HITea With GraceJune 22, 202600:02:34

ASCO Heard in the Halls: Dr. Spetzler on Agentic AI & Whole Genome Sequencing in Precision Oncology

Grace Vinton sits down with David Spetzler, MS, PhD, MBA, President of Caris Life Sciences, live from ASCO to talk about what's next for precision oncology.

Dr. Spetzler breaks down how Agentic AI is unlocking deeper, more powerful insights from genomic data, and what that means for patients right now. Plus, he shares the compelling proof behind whole genome sequencing and why research is showing that it leaves smaller panels in the dust. The bottom line? Smaller panels are keeping patients from life-saving therapies they may actually qualify for with whole genome sequencing.

Be sure to like and subscribe to HITea with Grace for honest conversations at the intersection of health, innovation, and technology.